Lotti Marcello, Moretto Angelo
Department of Environmental Medicine and Public Health, University of Padua, Padova, Italy.
Toxicol Rev. 2005;24(1):37-49. doi: 10.2165/00139709-200524010-00003.
Organophosphate-induced delayed polyneuropathy (OPIDP) is a rare toxicity resulting from exposure to certain organophosphorus (OP) esters. It is characterised by distal degeneration of some axons of both the peripheral and central nervous systems occurring 1-4 weeks after single or short-term exposures. Cramping muscle pain in the lower limbs, distal numbness and paraesthesiae occur, followed by progressive weakness, depression of deep tendon reflexes in the lower limbs and, in severe cases, in the upper limbs. Signs include high-stepping gait associated with bilateral foot drop and, in severe cases, quadriplegia with foot and wrist drop as well as pyramidal signs. In time, there might be significant recovery of the peripheral nerve function but, depending on the degree of pyramidal involvement, spastic ataxia may be a permanent outcome of severe OPIDP. Human and experimental data indicate that recovery is usually complete in the young. At onset, the electrophysiological changes include reduced amplitude of the compound muscle potential, increased distal latencies and normal or slightly reduced nerve conduction velocities. The progression of the disease, usually over a few days, may lead to non-excitability of the nerve with electromyographical signs of denervation. Nerve biopsies have been performed in a few cases and showed axonal degeneration with secondary demyelination. Neuropathy target esterase (NTE) is thought to be the target of OPIDP initiation. The ratio of inhibitory powers for acetylcholinesterase and NTE represents the crucial guideline for the aetiological attribution of OP-induced peripheral neuropathy. In fact, pre-marketing toxicity testing in animals selects OP insecticides with cholinergic toxicity potential much higher than that to result in OPIDP. Therefore, OPIDP may develop only after very large exposures to insecticides, causing severe cholinergic toxicity. However, this was not the case with certain triaryl phosphates that were not used as insecticides but as hydraulic fluids, lubricants and plasticisers and do not result in cholinergic toxicity. Several thousand cases of OPIDP as a result of exposure to tri-ortho-cresyl phosphate have been reported, whereas the number of cases of OPIDP as a result of OP insecticide poisoning is much lower. In this article, we mainly discuss OP pesticide poisoning, particularly when caused by chlorpyrifos, dichlorvos, isofenphos, methamidophos, mipafox, trichlorfon, trichlornat, phosphamidon/mevinphos and by certain carbamates. We also discuss case reports where neuropathies were not convincingly attributed to fenthion, malathion, omethoate/dimethoate, parathion and merphos. Finally, several observational studies on long-term, low-level exposures to OPs that sometimes reported mild, inconsistent and unexplained changes of unclear significance in peripheral nerves are briefly discussed.
有机磷酸酯诱导的迟发性多神经病(OPIDP)是一种因接触某些有机磷(OP)酯而导致的罕见毒性反应。其特征为在单次或短期接触后1 - 4周,外周和中枢神经系统的一些轴突发生远端变性。下肢出现肌肉痉挛性疼痛、远端麻木和感觉异常,随后逐渐出现无力,下肢深腱反射减弱,严重时上肢也会出现。体征包括与双侧足下垂相关的高抬腿步态,严重时出现四肢瘫伴足和腕下垂以及锥体束征。随着时间推移,外周神经功能可能会有显著恢复,但根据锥体束受累程度,痉挛性共济失调可能是严重OPIDP的永久性后果。人类和实验数据表明,年轻人的恢复通常是完全的。发病时,电生理变化包括复合肌肉动作电位幅度降低、远端潜伏期延长以及神经传导速度正常或略有降低。疾病通常在几天内进展,可能导致神经无兴奋性,伴有失神经的肌电图表现。少数病例进行了神经活检,显示轴突变性伴继发性脱髓鞘。神经病变靶酯酶(NTE)被认为是OPIDP发病的靶点。乙酰胆碱酯酶和NTE抑制能力的比值是OP诱导的外周神经病病因归因的关键指标。事实上,动物上市前毒性试验选择的OP杀虫剂具有比导致OPIDP高得多的胆碱能毒性潜力。因此,OPIDP可能仅在大量接触杀虫剂导致严重胆碱能毒性后才会发生。然而,某些三芳基磷酸酯并非用作杀虫剂,而是用作液压油、润滑剂和增塑剂,且不会导致胆碱能毒性,情况则有所不同。已报告了数千例因接触磷酸三邻甲苯酯而导致的OPIDP病例,而因OP杀虫剂中毒导致的OPIDP病例数量则少得多。在本文中,我们主要讨论OP农药中毒,特别是由毒死蜱、敌敌畏、异柳磷、甲胺磷、丙胺氟磷、敌百虫、蝇毒磷、磷胺/速灭磷以及某些氨基甲酸酯类引起的中毒。我们还讨论了一些病例报告,其中神经病变未能令人信服地归因于倍硫磷、马拉硫磷、氧乐果/乐果、对硫磷和地虫硫磷。最后,简要讨论了几项关于长期低水平接触OPs的观察性研究,这些研究有时报告外周神经出现轻微、不一致且意义不明的无法解释的变化。